ZYNE 1.3 (+0%)
US98986X1090• Drug Manufacturers• Drug Manufacturers - Specialty & Generic
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. ZYNE

Zynerba Pharmaceuticals (ZYNE) Competitor Comparison

We are evaluating the key criteria listed to compare Zynerba Pharmaceuticals (ZYNE) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Market Capitalization

47 / 54

Gross Profits

0 / 39

Total Revenue

0 / 50

EBITDA

47 / 53

Free Cashflow

40 / 54

Quick Ratio

8 / 54

Earnings per Share

36 / 54

Dividend yield

0 / 5

Total Cash

37 / 54

Performance 3 years

26 / 54

Performance 5 years

38 / 54

Performance 10 years

43 / 54

Linearity 3 years

23 / 54

Linearity 5 years

35 / 54

Linearity 10 years

43 / 54

Total Rank

24 / 54

Dividend Rank

41 / 54

Valuation Rank

53 / 54

Piotroski Rank

36 / 54

Muliplier Rank

12 / 54

Market Capitalization - ZYNE ranking 47 / 54

These are the competitors of Zynerba Pharmaceuticals in the industry Drug Manufacturers - Specialty & Generic ranked by market capitalization
1. Zoetis ZTS
91.12B
2. Teva Pharmaceutical Industries TEVA
15.07B
3. Vifor Pharma G2AB.F
11.62B
4. Catalent CTLT
10.52B
5. Elanco Animal Health ELAN
8.11B
6. Linc LNC
4.7B
7. Alvotech ALVO
4.33B
8. Perrigo PRGO
3.7B
9. Curaleaf Holdings CURLF
3.65B
10. Bausch Health Companies BHC
3.36B
11. Green Thumb Industries R9U2.F
2.85B
12. Amphastar Pharmaceuticals AMPH
2.66B
13. Ironwood Pharmaceuticals IRWD
2.38B
14. Amneal Pharmaceuticals AMRX
1.75B
15. Supernus Pharmaceuticals SUPN
1.68B
16. Taro Pharmaceutical Industries TARO
1.58B
17. Pacira BioSciences PCRX
1.39B
18. Tilray Brands TLRY
1.37B
19. ANI Pharmaceuticals ANIP
1.22B
20. Avadel Pharmaceuticals AVDL
1.2B
21. Collegium Pharmaceutical COLL
1.18B
22. Cronos Group CRON
881.4M
23. Evolus EOLS
839.84M
24. Embecta EMBC
830.29M
25. PetIQ PETQ
549.4M
26. Phibro Animal Health PAHC
539.51M
27. Organogenesis Holdings ORGO
470.1M
28. Harrow Health HROW
410.88M
29. Solid Biosciences SLDB
377.39M
30. Kamada KMDA
367.85M
31. Procaps Group PROC
345.24M
32. Ascend Wellness Holdings AAWH
294.13M
33. OptiNose OPTN
189.81M
34. Alimera Sciences ALIM
183.46M
35. Relmada Therapeutics RLMD
178.49M
36. Emergent BioSolutions EBS
171.22M
37. Ayr Wellness 3KJB.F
155.65M
38. Alpha Teknova TKNO
128.09M
39. Regencell Bioscience Holdings RGC
94.6M
40. ProPhase Labs PRPH
90.77M
41. Eagle Pharmaceuticals EGRX
83.45M
42. Journey Medical DERM
75.14M
43. Theratechnologies THTX
73.57M
44. SCYNEXIS SCYX
63.25M
45. Societal CDMO SCTL
54.7M
46. Cumberland Pharmaceuticals CPIX
31.75M
47. Zynerba Pharmaceuticals ZYNE
18.72M
48. Kolinpharma KIP.MI
17.06M
49. Jupiter Wellness JUPW
12.76M
50. Flora Growth FLGC
8.54M
51. Neoleukin Therapeutics NLTX
8.2M
52. Clever Leaves Holdings CLVR
7.3M
53. Universe Pharmaceuticals UPC
6.02M
54. Biofrontera BFRI
4.42M
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.